Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia

Clinical trial NCT07052838 · COMPLETED

Trial details

NCT number: NCT07052838
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Paroxysmal Nocturnal Haemoglobinuria (PNH)

Start date: 2025-05-12
Primary completion: 2025-12-23
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.